Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
2.
Ann Oncol ; 2023 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-37871699

RESUMEN

BACKGROUND: Oral SERDs are a novel drug class that have been developed to counteract resistance due to ESR1 mutations. Several SERDs have emerged from phase 2 and 3 trials, with the FDA limiting approval for Elacestrant to patients with ESR1mt tumours despite PFS benefit in the overall population. However, questions remain on whether patients with ESR1wt tumours stand to benefit from oral SERDs. PATIENTS AND METHODS: Manuscripts and conference presentations of Randomised Controlled Trials were extracted after a systematic search of Embase, PubMed and Cochrane from inception until January 21,2023. RCTs investigating the efficacy of oral SERDs versus endocrine therapy for ER positive, HER2 negative advanced breast cancer, and which reported the Kaplan Meier (KM) curves of PFS in the overall and ESR1 mutant (ESR1mt) population were selected. A graphical reconstructive algorithm was applied to estimate time-to-event outcomes from reported KM curves in all overall and ESR1mt cohorts. A bipartite matching algorithm, KMSubtraction, was used to derive survival data for unreported (ESR1wt) subgroups. An individual patient data (IPD) meta-analysis was then pursued, pooling data by ESR1 mutation status in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane Guidelines for IPD. RESULTS: The randomized clinical trials ACELERA, AMEERA-3, EMERALD and SERENA-2 were included, totalling 1290 patients. In the pooled analysis of the overall cohort, PFS benefit was observed with oral SERDs when compared with treatment of physicians choice (TPC) (HR 0.783, 95%CI 0.681-0.900, p<0.001). In the ESR1mt subgroup, oral SERDs demonstrated improved PFS (HR 0.557, 95%CI 0.440-0.705, p<0.001) compared to TPC. In the ESR1wt subgroup, oral SERDs demonstrated no significant PFS benefit (HR 0.944, 95%CI 0.783-1.138, p=0.543) when compared to TPC. CONCLUSIONS: The results of this IPD meta-analysis suggests that PFS benefit in the overall population is mainly driven by the ESR1mt subgroup.

3.
ACS Omega ; 8(30): 27079-27091, 2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-37546671

RESUMEN

A quaternary ammonium salt, 1,1'-(1,4-phenylenebis(methylene))bis(4-formylpyridin-1-ium) (PMBF), was synthesized, characterized, and investigated as an inhibitor for C1018 (type steel in oil wells) corrosion in 17.5% HCl solution. The chemical structure of PMBF was confirmed using altered techniques. Potentiodynamic polarization (PDP) was employed to investigate the corrosion inhibition effect of the synthesized compound in a 17.5% HCl solution for C1018. The corrosion protection was increased by improving the dose of the synthesized compound and reached 98.5% at 42.02 × 10-5 M and 313 K. On the other hand, it was decreased by increasing the temperature and reached 97.9% at the same concentration and 343 K. The parameters of activation and adsorption were calculated and debated. A polarization study revealed that PMBF functioned as a "mixed-kind inhibitor," i.e., affecting both cathodic and anodic processes through their adsorption onto the electrode surface. The adsorption was described by the Langmuir adsorption isotherm. Different techniques were employed as appropriate tools for analyzing the structure of the layer formed on C1018. Density functional theory (DFT) and Monte Carlo (MC) simulations were used to compare the results of the theoretical calculations with the experiments. Finally, an appropriate inhibition mechanism was suggested and discussed.

4.
BMC Psychiatry ; 23(1): 444, 2023 06 16.
Artículo en Inglés | MEDLINE | ID: mdl-37328751

RESUMEN

BACKGROUND: Psychosis treatment guidelines recommend cognitive behaviour therapy (CBT) and family intervention (FI), for all patients with first episode psychosis (FEP), though guidance borrows heavily from literature in adults from high income countries. To our knowledge, there are few randomized controlled trials (RCTs) examining the comparative effect of these commonly endorsed psychosocial interventions in individuals with early psychosis from high-income countries and no such trials from low and middle-income countries (LMICs). The present study aims to confirm the clinical-efficacy and cost-effectiveness of delivering culturally adapted CBT (CaCBT) and culturally adapted FI (CulFI) to individuals with FEP in Pakistan. METHOD: A multi-centre, three-arm RCT of CaCBT, CulFI, and treatment as usual (TAU) for individuals with FEP (n = 390), recruited from major centres across Pakistan. Reducing overall symptoms of FEP will be the primary outcome. Additional aims will include improving patient and carer outcomes and estimating the economic impact of delivering culturally appropriate psychosocial interventions in low-resource settings. This trial will assess the clinical-efficacy and cost-effectiveness of CaCBT and CulFI compared with TAU in improving patient (positive and negative symptoms of psychosis, general psychopathology, depressive symptoms, quality of life, cognition, general functioning, and insight) and carer related outcomes (carer experience, wellbeing, illness attitudes and symptoms of depression and anxiety). CONCLUSIONS: A successful trial may inform the rapid scale up of these interventions not only in Pakistan but other low-resource settings, to improve clinical outcomes, social and occupational functioning, and quality of life in South Asian and other minority groups with FEP. TRIAL REGISTRATION: NCT05814913.


Asunto(s)
Terapia Cognitivo-Conductual , Trastornos Psicóticos , Adulto , Humanos , Intervención Psicosocial , Trastornos Psicóticos/terapia , Terapia Cognitivo-Conductual/métodos , Resultado del Tratamiento , Ansiedad , Ensayos Clínicos Controlados Aleatorios como Asunto
5.
Clin Exp Dermatol ; 47(3): 553-560, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34674296

RESUMEN

BACKGROUND: The landscape of dermatology services, already rapidly evolving into an increasingly digital one, has been irretrievably altered by the COVID-19 (SARS-CoV-2) pandemic. Data are needed to assess how best to deliver virtual dermatology services in specific patient subgroups in an era of ongoing social distancing and beyond. Initial studies of teledermatology in paediatric populations suggest that many of the problems experienced in adult telemedicine are more apparent when treating children and come with additional challenges. AIM: To evaluate the efficacy of a virtual paediatric dermatology telephone clinic in comparison to traditional face-to-face (FTF) clinics, both from the clinician and patient/parental perspective. METHODS: We carried out a prospective service evaluation examining a single centre cohort of paediatric dermatology patients managed during the COVID-19 pandemic via a telephone clinic supported by images. The study period covered June-September 2020. Data on outcomes were collected from clinicians and a qualitative patient/parental telephone survey was undertaken separately. A five-point Likert scale was used to assess both satisfaction and levels of agreement regarding whether a telephone clinic was more convenient than an FTF clinic. RESULTS: Of 116 patients included, 24% were new and 76% were follow-up patients, with a mixture of inflammatory dermatoses (75%) and lesions (25%). From the clinician's perspective, most consultations (91%) were successfully completed over the telephone. However, qualitative patient and parent feedback paradoxically illustrated that although nearly all (98%) respondents had no outstanding concerns, 52% felt highly unsatisfied and only 22% agreed that telephone clinics were more convenient. Most (65%) preferred FTF follow-up in the future. Statistical analysis using χ² test showed that among those with established follow-ups, the preference for future consultation type was independent of specific reasons for follow-up. CONCLUSIONS: Our study demonstrates a clear discrepancy between the practical successes of a virtual service from the clinician's perspective compared with the patient/parental perspective. Parental anxiety appears to be less effectively allayed virtually than with FTF. This raises the question of whether there is a role for virtual paediatric telephone clinics in the postpandemic future, which may be better left to patients/parents to decide on an individual basis.


Asunto(s)
Actitud del Personal de Salud , Dermatología , Prioridad del Paciente , Satisfacción del Paciente , Consulta Remota , Adolescente , Instituciones de Atención Ambulatoria , COVID-19 , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Pandemias , Estudios Prospectivos , Encuestas y Cuestionarios
6.
Arch Razi Inst ; 77(3): 1191-1197, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-36618307

RESUMEN

Severe acute respiratory syndrome coronavirus-2 is a major threat to health care worldwide with high morbidity and mortality. Therefore, understanding the role of immune mechanisms and humoral response is vital in this disease. The present study aimed to investigate the relationship between Immunoglobulins (IgM, IgG) in COVID-19 recovered patients with age, gender, and severity of the disease. The duration of effect of antibody levels and protection against re-infection has also been evaluated in the patients. Three groups participated in this study; group 1: 0-14 days after recovery, group 2: 2 months after recovery, group 3: 3 months after recovery, group 4: 4-6 months after recovery, group 5: more than 6 months. The nasopharyngeal swab was used to confirm recovery by Real-Time Polymerase Chain Reaction (RT-PCR) technique. IgM and IgG antibody levels were evaluated using Enzyme-Linked Immuno Fluorescent Assay (ELIFA) technique. The results indicated that the IgM levels increased for one month during the seven days after infection and then decreased in most patients (P≤0.05). The mean of IgG in group 1 increased compared to those of other studied groups. A significant decrease was observed in group 2 compared to group 1, as well as in group 3 compared to groups 1, and 2. Also, a significant difference existed between group 4 compared to groups 1, 2, and 3. Finally, significant differences were noticed between group 5 compared to groups 1, 2, 3, and 4 (P≤0.05). No significant differences were observed in antibodies level between male, and female COVID-19 recovered patients in groups 1, 2, 3, 4, and 5 (P≤0.05). Finally, highly significant differences in IgG levels between mild, moderate, and severe subgroups in groups 1 and 2. The present study demonstrated that IgM and IgG against SARS-CoV-2 appeared in the early stages of the disease and decreased after 1 month and failed to maintain high levels during the 6-month observation.


Asunto(s)
COVID-19 , Femenino , Masculino , Anticuerpos Antivirales , COVID-19/epidemiología , Inmunoglobulina G , Inmunoglobulina M , Irak/epidemiología , SARS-CoV-2 , Humanos , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años
7.
J Family Med Prim Care ; 10(10): 3765-3771, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34934678

RESUMEN

BACKGROUND: Not many studies have investigated the knowledge outcomes among medical students with regards to contact lenses (CL). Thus, in this study, we aim to assess the attitude and awareness of CL use and the associated factors among medical students of King Faisal University (KFU), Al Ahsa, Saudi Arabia. METHODS: This a cross-sectional study that based developed based on a designed questionnaire that was composed of 31 questions with a maximum score of 57 points. We have also conducted a linear regression model to explore the possible important factors that may affect the level of knowledge and awareness about contact lenses care. RESULTS: A total of 208 participants were included in this study, with a mean age of 21.0 ± 1.9, and 56.3% (n = 117) of them being females. The total mean knowledge score in our study was 30.1 ± 7.74, which was higher in females (31.5 ± 7.09) than in male participants (28.7 ± 7.69). The results of the linear regression model showed that being female (E = -0.37; 95%CI = -0.65- -0.10; P = 0.007), using contact lenses (E = 0.56; 95%CI = 0.29 - 0.82; P < 0.001), and in the third year (E = 0.66; 95%CI = 0.19- 1.13; P = 0.007) is significantly correlated with having higher knowledge scores about using CLs. CONCLUSION: Female participants had higher total mean knowledge scores than males. We recommend that further educational campaigns should be inaugurated to raise awareness about taking care of CLs and enhancing the related practices of wearing them.

11.
Results Phys ; 19: 103610, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33520618

RESUMEN

A mathematical model for the spread of the COVID-19 disease based on a fractional Atangana-Baleanu operator is studied. Some fixed point theorems and generalized Gronwall inequality through the AB fractional integral are applied to obtain the existence and stability results. The fractional Adams-Bashforth is used to discuss the corresponding numerical results. A numerical simulation is presented to show the behavior of the approximate solution in terms of graphs of the spread of COVID-19 in the Chinese city of Wuhan. We simulate our table for the data of Wuhan from February 15, 2020 to April 25, 2020 for 70 days. Finally, we present a debate about the followed simulation in characterizing how the transmission dynamics of infection can take place in society.

13.
South Asian J Cancer ; 7(2): 91-95, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29721471

RESUMEN

Bone-modifying therapy is a primary research interest in breast cancer. Several features contribute to the importance of the bone environment in the management of breast cancer. Firstly, bone metastases represent the most common site of breast cancer metastases and secondly, the emergence of cancer treatment-induced bone loss (CTIBL) among breast cancer survivors and patients is of increasing concern. In the adjuvant setting, bisphosphonates can be given to prevent and treat tumor therapy-induced bone loss in premenopausal and postmenopausal women and, owing to their beneficial effect on bone turnover, have also been evaluated for prevention of bone metastases occurrence. Expert oncologists discusses on the update on the approaches of Bone-modifying Agents and its treatment options. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.

14.
Neural Netw ; 75: 150-61, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26797472

RESUMEN

This paper presents new Radial Basis Function (RBF) learning methods for classification problems. The proposed methods use some heuristics to determine the spreads, the centers and the number of hidden neurons of network in such a way that the higher efficiency is achieved by fewer numbers of neurons, while the learning algorithm remains fast and simple. To retain network size limited, neurons are added to network recursively until termination condition is met. Each neuron covers some of train data. The termination condition is to cover all training data or to reach the maximum number of neurons. In each step, the center and spread of the new neuron are selected based on maximization of its coverage. Maximization of coverage of the neurons leads to a network with fewer neurons and indeed lower VC dimension and better generalization property. Using power exponential distribution function as the activation function of hidden neurons, and in the light of new learning approaches, it is proved that all data became linearly separable in the space of hidden layer outputs which implies that there exist linear output layer weights with zero training error. The proposed methods are applied to some well-known datasets and the simulation results, compared with SVM and some other leading RBF learning methods, show their satisfactory and comparable performance.


Asunto(s)
Heurística Computacional , Aprendizaje Automático , Redes Neurales de la Computación , Estadística como Asunto/clasificación , Algoritmos , Humanos , Neuronas/fisiología , Factores de Tiempo
15.
Indian J Cancer ; 52(3): 449-52, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26905166

RESUMEN

BACKGROUND: The aim of this study was to look at the outcome of patients with metastatic pancreatic cancer treated at a tertiary cancer center in India. PATIENTS AND METHODS: A total of 101 patients with locally advanced and metastatic pancreatic cancer diagnosed between May 2012 and July 2013 were identified from a prospectively maintained database at the tertiary cancer center. Overall survival (OS) was computed using the Kaplan-Meir product limit method and compared across groups using the log-rank statistics. Cox proportional hazards model, adjusted for a number of patient and tumor characteristics, was then used to determine factors prognostic for OS. RESULTS: Median age at diagnosis was 55 years (range: 21-81 years). 57.4% (n = 58) of patients were male, 22% (n = 22) had performance status (PS) of <2 at diagnosis and 89% received first-line chemotherapy, while the rest received best supportive care. For the whole cohort, 6 month and 1-year OS was 57% (95% confidence interval [CI]: 46-66%) and 47% (95% CI: 35-57%), respectively. In a multivariable model, PS <2 and oligometastatic disease were associated with a significantly decreased risk of death. CONCLUSION: Results from our analysis indicate that the prognostic outcome among Indian patients with metastatic pancreatic cancer is poor with survival outcomes similar to those reported in North America and Europe.


Asunto(s)
Neoplasias Pancreáticas/terapia , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Neoplasias Pancreáticas/patología , Pronóstico , Estudios Prospectivos , Centros de Atención Terciaria , Adulto Joven
16.
Arch Pharm (Weinheim) ; 347(12): 896-907, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25251696

RESUMEN

A new series of pregnenonlone analogs were synthesized and evaluated for their inhibitory activity against cytochrome P450 (CYP17 hydroxylase enzyme). In general, the 5-aryl-1,3,4-thiadiazol-2-yl)-imino-pregnenolone derivatives 11-15 were more active than the sulfonate 24-31 and the ester 37-41 analogs. Derivative 12 showed optimal activity in this series, with IC50 values of 2.5 µM compared with the standard abiraterone (IC50 = 0.07 µM). However, the analogs 11 and 25 showed a better selectivity profile (81.5 and 82.7% inhibition of hydroxylase, respectively), which may be a useful lead in CYP17 inhibition studies. Molecular docking studies demonstrated quite similar binding patterns of all new pregnenolone derivatives at the active site of CYP17 through hydrogen bonding and hydrophobic interaction.


Asunto(s)
Diseño Asistido por Computadora , Inhibidores Enzimáticos del Citocromo P-450/síntesis química , Inhibidores Enzimáticos del Citocromo P-450/farmacología , Diseño de Fármacos , Simulación del Acoplamiento Molecular , Pregnenolona/síntesis química , Pregnenolona/farmacología , Esteroide 17-alfa-Hidroxilasa/antagonistas & inhibidores , Sitios de Unión , Dominio Catalítico , Inhibidores Enzimáticos del Citocromo P-450/metabolismo , Enlace de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Estructura Molecular , Pregnenolona/análogos & derivados , Pregnenolona/metabolismo , Relación Estructura-Actividad Cuantitativa , Proteínas Recombinantes/metabolismo , Esteroide 17-alfa-Hidroxilasa/metabolismo
17.
Indian J Cancer ; 51(1): 73-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24947101

RESUMEN

The management of hormone receptor-positive Her2-negative breast cancer patients with advanced or metastatic disease is a common problem in India and other countries in this region. This expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.


Asunto(s)
Neoplasias de la Mama/terapia , Consenso , Guías de Práctica Clínica como Asunto , Receptor ErbB-2/metabolismo , Receptores de Estrógenos/metabolismo , Receptores de Progesterona/metabolismo , Neoplasias de la Mama/metabolismo , Terapia Combinada , Manejo de la Enfermedad , Femenino , Humanos , Sociedades Médicas
18.
Ann Oncol ; 25(6): 1143-51, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24669011

RESUMEN

BACKGROUND: Our group has previously reported that women with inflammatory breast cancer (IBC) continue to have worse outcome compared with those with non-IBC. We undertook this population-based study to see if there have been improvements in survival among women with stage III IBC, over time. PATIENT AND METHODS: We searched the Surveillance, Epidemiology and End Results Registry to identify female patients diagnosed with stage III IBC between 1990 and 2010. Patients were divided into four groups according to year of diagnosis: 1990-1995, 1996-2000, 2001-2005, and 2006-2010. Breast cancer-specific survival (BCSS) was estimated using the Kaplan-Meier method and compared across groups using the log-rank test. Cox models were then fit to determine the association of year of diagnosis and BCSS after adjusting for patient and tumor characteristics. RESULTS: A total of 7679 patients with IBC were identified of whom 1084 patients (14.1%) were diagnosed between 1990 and 1995, 1614 patients (21.0%) between 1996 and 2000, 2683 patients (34.9%) between 2001 and 2005, and 2298 patients (29.9%) between 2006 and 2010. The 2-year BCSS for the whole cohort was 71%. Two-year BCSS were 62%, 67%, 72%, and 76% for patients diagnosed between 1990-1995, 1996-2000, 2001-2005, and 2006-2010, respectively (P < 0.0001). In the multivariable analysis, increasing year of diagnosis (modeled as a continuous variable) was associated with decreasing risks of death from breast cancer (HR = 0.98, 95% confidence interval 0.97-0.99, P < 0.0001). CONCLUSION: There has been a significant improvement in survival of patients diagnosed with IBC over a two-decade time span in this large population-based study. This suggests that therapeutic strategies researched and evolved in the context of non-IBC have also had a positive impact in women with IBC.


Asunto(s)
Neoplasias Inflamatorias de la Mama/mortalidad , Adulto , Anciano , Femenino , Humanos , Estimación de Kaplan-Meier , Persona de Mediana Edad , Modelos de Riesgos Proporcionales , Programa de VERF , Adulto Joven
19.
Iran J Parasitol ; 8(2): 190-6, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23914230

RESUMEN

BACKGROUND: Pteridine metabolic pathway is unusual features of Leishmania, which is necessary for the growth of parasite. Leishmania has evolved a complex and versatile pteridine salvage network which has the ability of scavenging a wide area of the conjugated and unconjugated pteridines especially folate and biopterin. In this study, we focus on the inhibition of ptr1 gene expression. METHODS: L. major ptr1 gene was cloned into pcDNA3 and digested using KpnI and BamHI. The gene was subcloned so that antisense will transcribe and called pcDNA-rPTR. Leishmania major was cultured and late logarithmic-phase promastigotes were harvested. The promastigotes were divided into two groups. One group was transfected with 50 µg of pcDNA-rPTR, whereas the other group was transfected with pcDNA3. Transfected cells were cultured and plated onto semi-solid media. Mouse pritonean macrophages were transfected using pcDNA-rPTR-tansfected promastigotes. Western blotting was performed on mouse transfected pritonean macrophages and extracts from transfected promastigotes of L. major using a L. major ptr1 antibody raised in rabbits. RESULTS: The PTR1 protein was not expressed in pcDNA-rPTR- tansfected promastigotes and mouse macrophage transfected with pcDNA-rPTR- tansfected promastigotes. CONCLUSION: This approach might be used to study the pteridine salvage pathway in Leishmania or to assess the possibility of using gene expression inhibition in the treatment of leishmaniasis.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA